| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Jan―05 |
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies |
Camille Bigenwald, Yacine Haddad, Cassandra Thelemaque, Agathe Carrier, Roxanne Birebent, Pierre Ly, et al. (+14) Caroline Flament, Imran Lahmar, Eric de Sousa, Markus Maeurer, Makoto Miyara, Tarek Assi, Cristina Castilla-Llorente, Christophe Willekens, Céline Fayemi, Julien Lazarovici, Aurélien Marabelle, Lisa Derosa, Vincent Ribrag, Laurence Zitvogel |
| 2 |
[GO] |
2022―Sep―07 |
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response |
Paola Storti, Valentina Marchica, Rosanna Vescovini, Valentina Franceschi, Luca Russo, Laura Notarfranchi, et al. (+9) Vincenzo Raimondi, Denise Toscani, Jessica Burroughs Garcia, Federica Costa, Benedetta Dalla Palma, Nicolas Thomas Iannozzi, Gabriella Sammarelli, Gaetano Donofrio, Nicola Giuliani |
| 3 |
[GO] |
2021―Jan―04 |
Immunological alternation in COVID-19 patients with cancer and its implications on mortality |
Guangyao Cai, Yue Gao, Shaoqing Zeng, Yang Yu, Xingyu Liu, Dan Liu, et al. (+5) Ya Wang, Ruidi Yu, Aakash Desai, Chunrui Li, Qinglei Gao |
| 4 |
[GO] |
2020―Dec―09 |
No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19 |
Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli, Pascale Gaussem, Syrine Ellouze, Georges Jourdi, et al. (+4) Eric Solary, Michaela Fontenay, David M. Smadja, Guido Kroemer |
| 5 |
[GO] |
2020―Sep―23 |
Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis |
Bolin Wang, Yan Huang |
| 6 |
[GO] |
2020―Aug―26 |
Immune responses during COVID-19 infection |
Cléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, Imran Lahmar, Agathe Dubuisson, Alimuddin Zumla, et al. (+16) Didier Raoult, Mansouria Merad, Bertrand Gachot, Clémence Hénon, Eric Solary, Michaela Fontenay, Fabrice André, Markus Maeurer, Giuseppe Ippolito, Mauro Piacentini, Fu-Sheng Wang, Florent Ginhoux, Aurélien Marabelle, Guido Kroemer, Lisa Derosa, Laurence Zitvogel |
| 7 |
[GO] |
2020―Jul―17 |
Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic? |
Shashi Gujar, Jonathan G. Pol, Youra Kim, Guido Kroemer |
| 8 |
[GO] |
2020―May―06 |
COVID-19: a challenge for oncology services |
Bertrand Routy, Lisa Derosa, Laurence Zitvogel, Guido Kroemer |
|